Raman Spectroscopy: An Emerging Tool in Neurodegenerative Disease Research and Diagnosis.
暂无分享,去创建一个
Sumeet Mahajan | A. Mudher | S. Mahajan | Amrit Mudher | George Devitt | Kelly Howard | George Devitt | K. Howard
[1] H. Beier,et al. Nanofluidic biosensing for beta-amyloid detection using surface enhanced Raman spectroscopy. , 2008, Nano letters.
[2] John K. J. Archer,et al. Near infrared Raman spectroscopy for Alzheimer's disease detection , 2005, European Conference on Biomedical Optics.
[3] H. Beier,et al. Application of Surface-Enhanced Raman Spectroscopy for Detection of Beta Amyloid Using Nanoshells , 2007 .
[4] S. S. Sinha,et al. Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer's Disease Biomarkers. , 2015, ACS applied materials & interfaces.
[5] I. Lednev,et al. Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementia , 2015, Journal of biophotonics.
[6] R. Dasari,et al. Ultrasensitive Chemical Analysis by Raman Spectroscopy , 1999 .
[7] C. Cowan,et al. Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers , 2015, Scientific Reports.
[8] R. Michael,et al. Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease. , 2012, Experimental eye research.
[9] Meikun Fan,et al. A review on the fabrication of substrates for surface enhanced Raman spectroscopy and their applications in analytical chemistry. , 2011, Analytica chimica acta.
[10] R. Goodacre,et al. The importance of protonation in the investigation of protein phosphorylation using Raman spectroscopy and Raman optical activity. , 2011, Analytical chemistry.
[11] Charles H. Camp,et al. High-Speed Coherent Raman Fingerprint Imaging of Biological Tissues , 2014, Nature Photonics.
[12] H. P. Lu,et al. Revealing the secondary structural changes of amyloid β peptide by probing the spectral fingerprint characters , 2013 .
[13] P. Lansbury,et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.
[14] Conor L Evans,et al. Raman technologies in cancer diagnostics. , 2016, The Analyst.
[15] R. Myers. Huntington’s disease genetics , 2004, NeuroRX.
[16] A. Shen,et al. Raman signature from brain hippocampus could aid Alzheimer's disease diagnosis. , 2009, Applied optics.
[17] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[18] H. Takeuchi,et al. Metal‐dependent α‐helix formation promoted by the glycine‐rich octapeptide region of prion protein , 1996, FEBS letters.
[19] Jeong-Woo Choi,et al. Surface-enhanced Raman scattering of dopamine on self-assembled gold nanoparticles. , 2011, Journal of nanoscience and nanotechnology.
[20] David I. Ellis,et al. Illuminating disease and enlightening biomedicine: Raman spectroscopy as a diagnostic tool. , 2013, The Analyst.
[21] Bappaditya Chandra,et al. Cell-Membrane-Mimicking Lipid-Coated Nanoparticles Confer Raman Enhancement to Membrane Proteins and Reveal Membrane-Attached Amyloid-β Conformation. , 2015, ACS nano.
[22] Ali Monfared,et al. Detection of amino acid neurotransmitters by surface enhanced Raman scattering and hollow core photonic crystal fiber , 2012, Other Conferences.
[23] E. Mandelkow,et al. Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.
[24] G. Fisone,et al. Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models. , 2013, Learning & memory.
[25] C. Cowan,et al. Are Tau Aggregates Toxic or Protective in Tauopathies? , 2013, Front. Neurol..
[26] B. Dietzek,et al. Coherent anti-Stokes Raman scattering and two photon excited fluorescence for neurosurgery , 2015, Clinical Neurology and Neurosurgery.
[27] G. Ricevuti,et al. Alzheimer disease and platelets: how’s that relevant , 2012, Immunity & Ageing.
[28] N. Maiti,et al. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. , 2006, Journal of molecular biology.
[29] Bernard Schneider,et al. α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer* , 2012, The Journal of Biological Chemistry.
[30] S. Lovestone,et al. GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.
[31] R. Lal,et al. Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] T. Creamer,et al. Polyproline II helical structure in protein unfolded states: Lysine peptides revisited , 2002, Protein science : a publication of the Protein Society.
[33] I. Prohovnik,et al. Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease , 2003, Dialogues in clinical neuroscience.
[34] R. Burke,et al. Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.
[35] K. Hajian‐Tilaki,et al. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. , 2013, Caspian journal of internal medicine.
[36] W. Tolles,et al. A Review of the Theory and Application of Coherent Anti-Stokes Raman Spectroscopy (CARS) , 1977 .
[37] Jane S. Paulsen. Cognitive Impairment in Huntington Disease: Diagnosis and Treatment , 2011, Current neurology and neuroscience reports.
[38] S. Dey,et al. Peroxidase to Cytochrome b Type Transition in the Active Site of Heme-Bound Amyloid β Peptides Relevant to Alzheimer's Disease. , 2016, Inorganic chemistry.
[39] George Perry,et al. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.
[40] G. Thomas,et al. Raman tensors and their application in structural studies of biological systems. , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[41] M. Luca,et al. - Secretase ADAM 10 as Well as APPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients , 2002 .
[42] M. Luca,et al. α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients , 2002, Molecular medicine.
[43] I. Kang,et al. Chitosan-gold Nano Composite for Dopamine Analysis using Raman Scattering , 2013 .
[44] X. G. Chen,et al. UV resonance Raman-selective amide vibrational enhancement: quantitative methodology for determining protein secondary structure. , 1998, Biochemistry.
[45] Dae Hwan Kim,et al. Label-free imaging and quantitative chemical analysis of Alzheimer’s disease brain samples with multimodal multiphoton nonlinear optical microspectroscopy , 2015, Journal of biomedical optics.
[46] Ian Todd,et al. ELISA in the multiplex era: Potentials and pitfalls , 2015, Proteomics. Clinical applications.
[47] Thomas J. Paul,et al. Structural and Mechanical Properties of Amyloid Beta Fibrils: A Combined Experimental and Theoretical Approach. , 2016, The journal of physical chemistry letters.
[48] I. Kang,et al. Fabrication of Chitosan-gold Nanocomposites Combined with Optical Fiber as SERS Substrates to Detect Dopamine Molecules , 2014 .
[49] M. Sawaya,et al. Structural Organization of Insulin Fibrils Based on Polarized Raman Spectroscopy: Evaluation of Existing Models. , 2015, Journal of the American Chemical Society.
[50] K. S. Krishnan,et al. A New Type of Secondary Radiation , 1928, Nature.
[51] Lutz Hecht,et al. Raman optical activity: a tool for protein structure analysis. , 2005, Structure.
[52] K. Fukumitsu,et al. NIR sensitivity enhancement by laser treatment for Si detectors , 2010 .
[53] David Eisenberg,et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.
[54] Isaiah Norton,et al. Label-Free Neurosurgical Pathology with Stimulated Raman Imaging. , 2016, Cancer research.
[55] N. Maiti,et al. Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein. , 2004, Journal of the American Chemical Society.
[56] Laurence D. Barron,et al. Rayleigh and Raman scattering from optically active molecules , 1971 .
[57] S. Hovmöller,et al. Conformations of amino acids in proteins. , 2002, Acta crystallographica. Section D, Biological crystallography.
[58] Ronald Wetzel,et al. Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions , 2006, Proceedings of the National Academy of Sciences.
[59] Alistair Elfick,et al. Raman Spectroscopy and Related Techniques in Biomedicine , 2010, Sensors.
[60] H. Banerjee,et al. Intraoperative brain cancer detection with Raman spectroscopy in humans. , 2016, Annals of translational medicine.
[61] R. Wetzel,et al. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.
[62] E. Monleón,et al. Raman analysis of prion protein in blood cell membranes from naturally affected scrapie sheep. , 2004, Chemistry & biology.
[63] Ewan W Blanch,et al. A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. , 2002, European journal of biochemistry.
[64] M. Vasák,et al. Solution structure of native proteins with irregular folds from Raman optical activity. , 2001, Biopolymers.
[65] C. Masters,et al. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. , 2003, Lancet.
[66] R. Jiji,et al. Resolution of localized small molecule-Aβ interactions by deep-ultraviolet resonance Raman spectroscopy. , 2011, Biophysical chemistry.
[67] S. Rivas-Arancibia,et al. Structural Changes of Amyloid Beta in Hippocampus of Rats Exposed to Ozone: A Raman Spectroscopy Study , 2017, Front. Mol. Neurosci..
[68] Hope T. Beier,et al. A surface enhanced Raman spectroscopy platform based on nanoshells for detection of β-amyloid , 2008, SPIE BiOS.
[69] P. Carmona,et al. Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer’s disease , 2015, Analytical and Bioanalytical Chemistry.
[70] M. Maffia,et al. Monitoring prion protein expression in complex biological samples by SERS for diagnostic applications , 2010, Nanotechnology.
[71] S. Bykov,et al. Peptide secondary structure folding reaction coordinate: correlation between uv raman amide III frequency, Psi Ramachandran angle, and hydrogen bonding. , 2006, The journal of physical chemistry. B.
[72] P. Martínez-Martín,et al. Discrimination analysis of blood plasma associated with Alzheimer's disease using vibrational spectroscopy. , 2013, Journal of Alzheimer's disease : JAD.
[73] Regina M Murphy,et al. Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation. , 2009, Journal of molecular biology.
[74] Camilo L. M. Morais,et al. Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood , 2017, Proceedings of the National Academy of Sciences.
[75] Ming Xu,et al. Dissecting structure of prion amyloid fibrils by hydrogen-deuterium exchange ultraviolet Raman spectroscopy. , 2012, The journal of physical chemistry. B.
[76] Andreas Vitalis,et al. Characterizing the conformational ensemble of monomeric polyglutamine , 2005, Proteins.
[77] R. V. Van Duyne,et al. Exploring the structure and formation mechanism of amyloid fibrils by Raman spectroscopy: a review. , 2015, The Analyst.
[78] Herman L. Offerhaus,et al. Polyglutamine Aggregate Structure In Vitro and In Vivo; New Avenues for Coherent Anti-Stokes Raman Scattering Microscopy , 2012, PloS one.
[79] H. Anis,et al. Surface-Enhanced Raman Scattering Spectroscopy for the Detection of Glutamate and $\gamma$-Aminobutyric Acid in Serum by Partial Least Squares Analysis , 2015, IEEE Photonics Journal.
[80] Saulius Juodkazis,et al. Statistically quantified measurement of an Alzheimer's marker by surface‐enhanced Raman scattering , 2015, Journal of biophotonics.
[81] T. Creamer,et al. Evidence for polyproline II helical structure in short polyglutamine tracts. , 2006, Journal of molecular biology.
[82] M. Maffia,et al. SERS based optical sensor to detect prion protein in neurodegenerate living cells , 2011 .
[83] William J. Tipping,et al. Stimulated Raman Scattering Microscopy: An Emerging Tool for Drug Discovery , 2016 .
[84] M Muratore,et al. Raman spectroscopy and partial least squares analysis in discrimination of peripheral cells affected by Huntington's disease. , 2013, Analytica chimica acta.
[85] Nigel J. Cairns,et al. Proteopathic tau seeding predicts tauopathy in vivo , 2014, Proceedings of the National Academy of Sciences.
[86] A. Shen,et al. Laser Raman detection of platelet as a non-invasive approach for early and differential diagnosis of Alzheimer's disease , 2011 .
[87] C. Rowlands,et al. Label-free molecular analysis of live Neospora caninum tachyzoites in host cells by selective scanning Raman micro-spectroscopy. , 2012, The Analyst.
[88] M. Diamond,et al. The prion model for progression and diversity of neurodegenerative diseases , 2017, The Lancet Neurology.
[89] Francis L Martin,et al. Extracting biological information with computational analysis of Fourier-transform infrared (FTIR) biospectroscopy datasets: current practices to future perspectives. , 2012, The Analyst.
[90] Aufried T. M. Lenferink,et al. Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study. , 2014, Experimental eye research.
[91] Abel Rodríguez,et al. Early Onset Prion Disease from Octarepeat Expansion Correlates with Copper Binding Properties , 2009, PLoS pathogens.
[92] Jeong-Woo Choi,et al. Fabrication of gold nanoparticle modified ITO substrate to detect beta-amyloid using surface-enhanced Raman scattering. , 2011, Journal of nanoscience and nanotechnology.
[93] Annalisa Pastore,et al. Solution structure of polyglutamine tracts in GST‐polyglutamine fusion proteins , 2002, FEBS letters.
[94] M. Goedert. The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies , 2016, Alzheimer's & Dementia.
[95] G. Niaura,et al. Surface-enhanced Raman spectroscopy for detection of toxic amyloid β oligomers adsorbed on self-assembled monolayers. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[96] Edmund Koch,et al. Assessing the efficacy of coherent anti‐Stokes Raman scattering microscopy for the detection of infiltrating glioblastoma in fresh brain samples , 2017, Journal of biophotonics.
[97] R. Venkatramani,et al. pH changes the aggregation propensity of amyloid-β without altering the monomer conformation. , 2014, Physical chemistry chemical physics : PCCP.
[98] Hidetoshi Sato,et al. Raman endoscopy for the in situ investigation of advancing colorectal tumors in live model mice. , 2013, The Analyst.
[99] H. Takeuchi,et al. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. , 2005, Biochemistry.
[100] M. Goedert,et al. Invited review: Prion‐like transmission and spreading of tau pathology , 2015, Neuropathology and applied neurobiology.
[101] Rekha Gautam,et al. Review of multidimensional data processing approaches for Raman and infrared spectroscopy , 2015, EPJ Techniques and Instrumentation.
[102] S. Sánchez‐Cortés,et al. Surface‐enhanced Raman spectroscopy of γ‐aminobutyric acid on silver colloid surfaces , 1997 .
[103] D P Salmon,et al. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. , 1990, Archives of neurology.
[104] R. Goodacre,et al. Quantification of casein phosphorylation with conformational interpretation using Raman spectroscopy. , 2007, The Analyst.
[105] U. Tamer,et al. A SERS-based sandwich assay for ultrasensitive and selective detection of Alzheimer's tau protein. , 2013, Biomacromolecules.
[106] M. Goedert,et al. Propagation of Tau aggregates , 2017, Molecular Brain.
[107] Hideo Takeuchi,et al. Binding of iron(III) to the single tyrosine residue of amyloid β-peptide probed by Raman spectroscopy , 2001 .
[108] Wei Min,et al. Coherent nonlinear optical imaging: beyond fluorescence microscopy. , 2011, Annual review of physical chemistry.
[109] O. Maes,et al. Spectroscopy of human plasma for diagnosis of idiopathic Parkinson's disease. , 2008, Biomarkers in medicine.
[110] S. Haswell,et al. Metal imbalance and compromised antioxidant function are early changes in prion disease. , 2002, The Biochemical journal.
[111] R. Jiji,et al. Insights into the aggregation mechanism of Aβ(25-40). , 2017, Biophysical chemistry.
[112] ScienceDirect,et al. Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment , 1984 .
[113] P E Wright,et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[114] Jayant B Udgaonkar,et al. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation. , 2014, Biochemistry.
[115] J. Pelton,et al. Spectroscopic methods for analysis of protein secondary structure. , 2000, Analytical biochemistry.
[116] Yang Yang,et al. Copper Ion Binding Site in β-Amyloid Peptide. , 2016, Nano letters.
[117] T. Spiro,et al. Resonance Raman spectra of heme proteins. Effects of oxidation and spin state. , 1974, Journal of the American Chemical Society.
[118] A. Kaczor,et al. Raman spectroscopy of proteins: a review , 2013 .
[119] Sanford A. Asher,et al. UV resonance Raman studies of peptide conformation in poly(L-lysine), poly(L-glutamic acid), and model complexes: the basis for protein secondary structure determinations , 1989 .
[120] K. Jeong,et al. Nanoplasmonic biopatch for in vivo surface enhanced raman spectroscopy , 2014, BioChip Journal.
[121] Christian Humpel,et al. Identifying and validating biomarkers for Alzheimer's disease , 2011, Trends in biotechnology.
[122] S. Asher,et al. UV resonance Raman spectroscopy monitors polyglutamine backbone and side chain hydrogen bonding and fibrillization. , 2012, Biochemistry.
[123] Ewan W Blanch,et al. A new perspective on beta-sheet structures using vibrational Raman optical activity: from poly(L-lysine) to the prion protein. , 2003, Journal of the American Chemical Society.
[124] V. Uversky. Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders , 2015, Front. Aging Neurosci..
[125] P. Bouř,et al. An Experimental Comparison of Vibrational Circular Dichroism and Raman Optical Activity with 1-Amino-2-propanol and 2-Amino-1-propanol as Model Compounds , 1997 .
[126] J. Trojanowski,et al. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. , 2006, Annual review of pathology.
[127] L. Mucke,et al. Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.
[128] Markus Tolnay,et al. “Prion‐Like” Templated Misfolding in Tauopathies , 2013, Brain pathology.
[129] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[130] Dustin W. Shipp,et al. Raman spectroscopy: techniques and applications in the life sciences , 2017 .
[131] J. Mcdermott,et al. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. , 1995, Biochemical and biophysical research communications.
[132] A. Enejder,et al. Plaque-associated lipids in Alzheimer’s diseased brain tissue visualized by nonlinear microscopy , 2015, Scientific Reports.
[133] R. Martins,et al. The involvement of lipids in Alzheimer's disease. , 2014, Journal of genetics and genomics = Yi chuan xue bao.
[134] L. Grinberg,et al. Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.
[135] S. Asher,et al. Comparison between UV Raman and circular dichroism detection of short alpha helices in bombolitin III. , 2002, Biochemistry.
[136] H. Takeuchi,et al. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. , 2000, Biochemistry.
[137] J. Koenig. Raman spectroscopy of biological molecules: A review , 1972 .
[138] J. Collinge,et al. The cognitive profile of prion disease: a prospective clinical and imaging study , 2015, Annals of clinical and translational neurology.
[139] D. Eliezer,et al. Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.
[140] H. Takeuchi,et al. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. , 1999, Biochemistry.
[141] R. Subramaniam,et al. Brain PET in the Diagnosis of Alzheimer’s Disease , 2014, Clinical nuclear medicine.
[142] C Caltagirone,et al. Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease , 2004, Neurology.
[143] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[144] K. Bötzel,et al. Prevalence and incidence of Parkinson's disease in Europe , 2005, European Neuropsychopharmacology.
[145] R. D'Hooge,et al. Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice , 2007, The EMBO Journal.
[146] H. Kuroda. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid. , 1983, Acta medica Okayama.
[147] F. Chiti,et al. SERS Detection of Amyloid Oligomers on Metallorganic-Decorated Plasmonic Beads. , 2015, ACS applied materials & interfaces.
[148] S. Asher,et al. Dihedral psi angle dependence of the amide III vibration: a uniquely sensitive UV resonance Raman secondary structural probe. , 2001, Journal of the American Chemical Society.
[149] N. Isaacs,et al. Raman optical activity and circular dichroism reveal dramatic differences in the influence of divalent copper and manganese ions on prion protein folding. , 2008, Biochemistry.
[150] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[151] Inhee Choi,et al. Ultra-sensitive, label-free probing of the conformational characteristics of amyloid beta aggregates with a SERS active nanofluidic device , 2012 .
[152] C. Roberts,et al. Investigations of the supramolecular structure of individual diphenylalanine nano- and microtubes by polarized Raman microspectroscopy. , 2012, Biomacromolecules.
[153] A. Shen,et al. Detection of Alzheimer's disease by Raman spectra of rat's platelet with a simple feature selection , 2013 .
[154] T. He,et al. Surface enhanced Raman scattering-active worm-like Ag clusters for sensitive and selective detection of dopamine , 2015 .
[155] J. Weuve,et al. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census , 2013, Neurology.
[156] R. Zbořil,et al. Magnetically assisted surface-enhanced raman scattering selective determination of dopamine in an artificial cerebrospinal fluid and a mouse striatum using Fe(3)O(4)/Ag nanocomposite. , 2014, Analytical chemistry.